Pathways to Prevention (Protocol TN-01)
Summary
This study will help us learn more about how type 1 diabetes occurs as well as help us to identify people who may be eligible for prevention trials through screening. By ongoing monitoring, we will compare people with and without auto-antibodies to help us better understand differences over time.
Eligibility
Eligible ages: 2 to 45
Accepts healthy participants: Yes
Inclusion criteria:
- 2 to 45 years old and have a brother, sister, child, or parent with type 1 diabetes.
- 2 to 20 years old and have a cousin, aunt, uncle, niece, nephew, half-brother, half-sister, or grandparent with type 1 diabetes.
- Individuals (age 2 years - 45 years) who have diabetes related autoantibodies found though external screening
Exclusion criteria:
Individuals with Type 1 diabetes
Participate
Fill out the following form if you want to participate in this research
UCalgary Notice of Collection
The University of Calgary (UCalgary) respects your privacy and is
committed to ensuring the privacy of all students, staff, and community members. Your personal information is being
collected under the authority of section 4(c) of the Protection of Privacy Act (POPA). It will be collected, used
and disclosed for the purposes outlined in UCalgary’s
Notice of
Collection, Use and Disclosure of Personal Information and managed in accordance with UCalgary’s
Privacy
Management Program.
Your personal information may be input into automated systems to generate content or make decisions,
recommendations, or predictions. If you have questions regarding this notice or UCalgary’s collection,
use, or disclosure of your personal information, please contact
accessandprivacy@ucalgary.ca.
Additional information
Contact information
Heidi.Virtanen@ahs.ca 403-955-8866
Principal investigator:
Carol Huang
Clinical trial:
No
REB-ID:
REB14-2465
External links